NDC 0480-7250 – Liraglutide

Liraglutide 6 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0480-7250

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA214568
Marketed since
August 28, 2025
Marketing end
September 30, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (1)

Package NDCDescriptionSince
0480-7250-465 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTICAug 28, 2025

Other Liraglutide products